Read
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Devastated by tornado
A huge tornado tears through the Oklahoma City suburb of Moore, killing dozens. Slideshow
Nuclear tsunami wall
Safety upgrades designed to prevent a repeat of the Fukushima disaster. Slideshow
Sponsored Links
EU agency backs Novartis' Votubia for kidney tumors
A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011.
Credit: Reuters/Arnd Wiegmann
ZURICH |
ZURICH (Reuters) - European regulators on Friday recommended approval of a Novartis' drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC).
The Committee for Medicinal Products for Human Use (CHMP) issued a positive recommendation for Votubia also known as evorolimus for the treatment of adult patients with renal angiomyolipoma associated with TSC.
Evorolimus is already approved in the United States under the name Afinitor for the treatment of TSC.
(Reporting by Caroline Copley)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters